On November 20, Inovio Pharmaceuticals, Inc. reported positive results in preclinical trials of the first DNA synthetic vaccine against the Middle East Respiratory Syndrome Coronavirus
On November 20, Inovio Pharmaceuticals, Inc. reported positive results in preclinical trials of the first DNA synthetic vaccine against the Middle East Respiratory Syndrome Coronavirus